West Pharmaceutical Services, Inc.WST
NYSE•Healthcare•Medical Instruments & Supplies
Understand cash generation quality and how management allocates capital.
Free cash flow was $47.20M in the latest quarter (18.8% decrease YoY). FCF margin is 1.5%. Shares outstanding declined by 0.7% year-over-year, indicating buybacks (returning capital to shareholders). Free cash flow is the lifeblood of a business — it funds dividends, buybacks, debt reduction, and reinvestment without relying on external capital.
Free cash flow, earnings quality, and capital allocation